Callan JMB, Inc. (CJMB) AI Stock Analysis

• Market Cap: $17.45M
• Dividend Yield: N/A
• Average Volume (3M): 10.79K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.63
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 26
• Sector: Real Estate
• Sector Strength: 53
• Industry: Integrated Freight & Logistics
• EPS (TTM): N/A
• Shares Outstanding: 4,481,069
• 10 Day Avg. Volume: 12,214
• 30 Day Avg. Volume: 10,793
• PEG Ratio: 0.02
• Price to Book (P/B): 3.32
• Price to Sales (P/S): 1.60
• P/FCF Ratio: 21.29
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $2.50 ▲(0.00% Upside)

Callan JMB, Inc. is facing significant financial and technical challenges. The most impactful factor is the company's declining financial performance, with notable losses and liquidity concerns. Technical analysis also indicates bearish momentum, with the stock trading below key moving averages and in oversold conditions. The absence of valuation metrics further complicates the investment outlook, leading to a low overall stock score.

Positive Factors

Technology Upgrade

The upgrade to Sentry 4.0 enhances product flexibility and accessibility, potentially increasing customer satisfaction and retention, which can drive long-term revenue growth.

Revenue Diversification

A diversified revenue model reduces dependency on any single income stream, providing stability and resilience against market fluctuations, supporting sustainable growth.

Positive Free Cash Flow

Positive free cash flow indicates that the company can fund its operations and growth initiatives internally, reducing reliance on external financing and enhancing financial stability.

Negative Factors

Declining Revenue

Declining revenue suggests challenges in market competitiveness or product demand, which can hinder long-term growth and profitability if not addressed.

Operational Inefficiencies

Operational inefficiencies can lead to increased costs and reduced profitability, impacting the company's ability to compete effectively and sustain growth.

Decreased Equity and Assets

A decrease in equity and assets may limit the company's ability to invest in growth opportunities and could signal financial instability, affecting long-term viability.

Callan JMB, Inc. Business Overview & Revenue Model

Company Description

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.

How the Company Makes Money

CJMB generates revenue primarily through three key streams: software sales, consulting services, and subscription-based models for its cloud solutions. Software sales involve direct transactions for proprietary applications, while consulting services are billed on a project basis or through retainers for ongoing advisory support. Additionally, the company has developed a subscription model for its cloud-based offerings, providing clients with continuous access to software updates and support, which contributes to recurring revenue. Strategic partnerships with technology providers and industry leaders further enhance CJMB's market reach and credibility, allowing for collaborative projects that also drive additional income.

Callan JMB, Inc. Financial Statement Overview

Summary

The company faces significant financial challenges with declining revenues and profitability. The income statement shows a substantial net loss, while the balance sheet reflects a decrease in equity and assets. Cash flow analysis indicates potential liquidity issues, although positive free cash flow is maintained.

Income Statement

The income statement shows a concerning decline in revenue and profitability. The gross profit margin has decreased significantly, and the company has moved from a positive net income in previous years to a substantial net loss in the most recent year. The negative EBIT and EBITDA margins indicate operational inefficiencies and potential challenges in cost management.

Balance Sheet

The balance sheet reflects a moderate financial position with a relatively low debt-to-equity ratio, suggesting manageable leverage. However, the substantial decrease in stockholders' equity and total assets raises concerns about the company's ability to sustain its operations and growth. The equity ratio remains strong, indicating a solid capital structure despite recent declines.

Cash Flow

Cash flow analysis reveals a significant decline in operating cash flow and free cash flow compared to previous years, indicating potential liquidity issues. The free cash flow to net income ratio has deteriorated, reflecting challenges in converting income into cash. Despite these concerns, the company has managed to maintain positive free cash flow, which is a positive aspect.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	5.91M	6.56M	13.20M	22.77M
Gross Profit	2.17M	2.56M	5.65M	9.45M
EBITDA	-6.48M	-2.12M	2.30M	6.37M
Net Income	-6.66M	-2.29M	2.18M	6.22M
Balance Sheet
Total Assets	7.74M	5.08M	9.71M	15.25M
Cash, Cash Equivalents and Short-Term Investments	2.79M	2.10M	5.16M	6.19M
Total Debt	2.07M	907.45K	400.00K	410.88K
Total Liabilities	3.56M	1.91M	910.27K	1.24M
Stockholders Equity	4.18M	3.17M	8.80M	14.01M
Cash Flow
Free Cash Flow	-5.23M	494.19K	6.51M	8.94M
Operating Cash Flow	-4.61M	540.35K	7.00M	9.36M
Investing Cash Flow	-616.90K	-46.17K	-490.02K	-422.49K
Financing Cash Flow	5.21M	-3.55M	-7.54M	-4.57M

Callan JMB, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.50
• 50DMA: Negative
• 100DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CJMB, the sentiment is Negative. The current price of 2.5 is below the 20-day moving average (MA) of 3.85, below the 50-day MA of 4.34, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.26 indicates Positive momentum. The RSI at 29.52 is Positive, neither overbought nor oversold. The STOCH value of 25.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CJMB.

Callan JMB, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
GVH	60 Neutral	$4.80M	0.49	18.17%	―	22.89%	-46.58%
PSIG	47 Neutral	$13.43M	―	―	―	―	―
CJMB	41 Neutral	$17.45M	―	―	―	―	―